down arrow

Transgene Biotek

  • Market Cap: Micro Cap
  • Industry: Hospital & Healthcare Services
  • ISIN: INE773D01018
  • NSEID:
  • BSEID: 526139
INR
3.65
0.00 (0.00%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 8.94 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Global Health
Fortis Health.
Narayana Hrudaya
Apollo Hospitals
Max Healthcare
Family Care
Chennai Meena
Nidan Laborator.
Transgene Biotek
Global Longlife
KK Shah Hospital
Why is Transgene Biotek Ltd ?
Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report
Verdict Report
Icon
No Data Found
Is Transgene Biotek for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Transgene Biotek
-54.71%
-1.09
50.17%
SENSEX
0.45%
0.03
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
4.40%
EBIT Growth (5y)
13.86%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-24.81%
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
55
Price to Book Value
2.55
EV to EBIT
-41.60
EV to EBITDA
-41.60
EV to Capital Employed
1.68
EV to Sales
41.60
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-3.84%
ROE (Latest)
-2.40%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
PAT(9M)

Higher at Rs 0.04 Cr

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Transgene Biotek
Profit After Tax (PAT) - Nine Monthly
Higher at Rs 0.04 Cr
than preceding 12 month period ended Dec 2024 of Rs -0.66 cr
MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months

PAT (Rs Cr)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."